We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Japan Clarifies Clinical Requirements for Companion Diagnostics
Japan Clarifies Clinical Requirements for Companion Diagnostics
Companies filing premarket approval applications for in vitro companion diagnostics may explain the clinical significance and clinical cut-off of their products using a summary of the clinical results for the corresponding drug product, Japan’s Pharmaceuticals and Medical Devices Agency says in recent technical guidance.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor